Cargando…
Topical non‐steroidal anti‐inflammatory drugs are not the mainstay of prophylaxis and treatment for pseudophakic cystoid macular oedema
Autores principales: | Levitz, Lewis M., Lim, Chris H. L., Grzybowski, Andrzej, Kim, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899707/ https://www.ncbi.nlm.nih.gov/pubmed/31313428 http://dx.doi.org/10.1111/ceo.13591 |
Ejemplares similares
-
Pseudophakic cystoid macular edema: update 2016
por: Grzybowski, Andrzej, et al.
Publicado: (2016) -
Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac
por: Sengupta, Sabyasachi, et al.
Publicado: (2018) -
Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema
por: Maleki, Arash, et al.
Publicado: (2018) -
Pseudophakic Cystoid Macular Oedema (PCME) Prevention in Patients with Non-Proliferative Diabetic Retinopathy (NPDR)—Randomized Controlled Trial
por: Jukić, Anđela, et al.
Publicado: (2022) -
Pseudophakic Cystoid Macular Edema Associated with Extrafoveal Vitreoretinal Traction
por: Martinez, Michael R, et al.
Publicado: (2011)